Literature DB >> 8238539

Involvement of neurogenic inflammation in antigen-induced bronchoconstriction in guinea pigs.

C Bertrand1, P Geppetti, P D Graf, A Foresi, J A Nadel.   

Abstract

The role of tachykinins released from sensory nerves in bronchoconstriction induced by antigen was studied in sensitized guinea pigs anesthetized with pentobarbital sodium and pretreated with atropine. The combination of NK2 (SR-48968) and NK1 (CP-96,345) tachykinin-receptor antagonists abolished the increase in total pulmonary resistance (RL) evoked by intravenous capsaicin but did not affect the response evoked by intravenous histamine. A small dose of aerosolized ovalbumin (OVA, 0.1%) produced a small increase in RL that was further increased and markedly prolonged by the neutral endopeptidase (NEP) inhibitor phosphoramidon; this bronchoconstrictor effect of OVA was markedly reduced by the NK2-receptor antagonist and was abolished by the combination of the NK1 and NK2-receptor antagonists together. When a larger dose of OVA (0.5%) was used, a maximal bronchoconstrictor response was obtained. Phosphoramidon did not potentiate this response significantly. The combination of NK1- and NK2-receptor antagonists blunted the response at 5 min only slightly but markedly attenuated the later (10-20 min) response. These results show that tachykinins released from sensory nerves play a significant role in antigen-induced bronchoconstriction in guinea pigs. This effect is exaggerated when the normal modulation of neuropeptides by NEP is inhibited and is mediated predominantly by NK2-receptor activation, with a smaller contribution by NK1 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238539     DOI: 10.1152/ajplung.1993.265.5.L507

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  KW-4679-induced inhibition of tachykininergic contraction in the guinea-pig bronchi by prejunctional inhibition of peripheral sensory nerves.

Authors:  T Ikemura; K Okarmura; Y Sasaki; H Ishi; K Ohmori
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Inhibition of bradykinin-evoked trigeminal nerve stimulation by the non-peptide bradykinin B2 receptor antagonist WIN 64338 in vivo and in vitro.

Authors:  J M Hall; M Figini; S K Butt; P Geppetti
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Effect of the long-acting tachykinin NK(1) receptor antagonist MEN 11467 on tracheal mucus secretion in allergic ferrets.

Authors:  S Khan; Y C Liu; A M Khawaja; S Manzini; D F Rogers
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigs.

Authors:  E Boichot; N Germain; V Lagente; C Advenier
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

5.  Role of tachykinin NK2-receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea-pigs.

Authors:  M Schuiling; A B Zuidhof; H Meurs; J Zaagsma
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs.

Authors:  F L Ricciardolo; J A Nadel; P D Graf; C Bertrand; S Yoshihara; P Geppetti
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

7.  Interaction Between Daidzein and Hesperetin on Antispasmodic Action in Isolated Sensitized and Non-sensitized Guinea-Pig Tracheas.

Authors:  Chung-Hung Shih; Tsu-Ya Chang; Wun-Chang Ko
Journal:  Front Pharmacol       Date:  2016-03-29       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.